MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,521,000 | +64.3% | 124,262 | -0.2% | 0.05% | +51.6% |
| Q2 2020 | $3,968,000 | +12.0% | 124,560 | +12.7% | 0.03% | -6.1% |
| Q1 2020 | $3,544,000 | +11.5% | 110,541 | +3.7% | 0.03% | +37.5% |
| Q4 2019 | $3,179,000 | +137.2% | 106,597 | +15.0% | 0.02% | +118.2% |
| Q3 2019 | $1,340,000 | +48.7% | 92,721 | +0.1% | 0.01% | +57.1% |
| Q2 2019 | $901,000 | -37.4% | 92,636 | -5.0% | 0.01% | -41.7% |
| Q1 2019 | $1,439,000 | +37.6% | 97,498 | +6.2% | 0.01% | +33.3% |
| Q4 2018 | $1,046,000 | -0.3% | 91,808 | +20.7% | 0.01% | +12.5% |
| Q3 2018 | $1,049,000 | -55.3% | 76,032 | -7.3% | 0.01% | -50.0% |
| Q2 2018 | $2,349,000 | +42.3% | 82,000 | +1.5% | 0.02% | +33.3% |
| Q1 2018 | $1,651,000 | +29.8% | 80,758 | +3.2% | 0.01% | +50.0% |
| Q4 2017 | $1,272,000 | +10.0% | 78,262 | -2.8% | 0.01% | 0.0% |
| Q3 2017 | $1,156,000 | -2.6% | 80,549 | +14.0% | 0.01% | -11.1% |
| Q2 2017 | $1,187,000 | +18.0% | 70,650 | -1.7% | 0.01% | +12.5% |
| Q1 2017 | $1,006,000 | -8.4% | 71,875 | +5.4% | 0.01% | -11.1% |
| Q4 2016 | $1,098,000 | +51.9% | 68,223 | +7.6% | 0.01% | +50.0% |
| Q3 2016 | $723,000 | -6.8% | 63,406 | -0.0% | 0.01% | -14.3% |
| Q2 2016 | $776,000 | +28.1% | 63,430 | +0.2% | 0.01% | +40.0% |
| Q1 2016 | $606,000 | -34.2% | 63,275 | -0.5% | 0.01% | -44.4% |
| Q4 2015 | $921,000 | -11.4% | 63,614 | +0.5% | 0.01% | -10.0% |
| Q3 2015 | $1,039,000 | -62.1% | 63,302 | -47.3% | 0.01% | -16.7% |
| Q2 2015 | $2,740,000 | +275.3% | 120,094 | +150.1% | 0.01% | +100.0% |
| Q1 2015 | $730,000 | -33.2% | 48,023 | -47.1% | 0.01% | +20.0% |
| Q4 2014 | $1,092,000 | +110.8% | 90,754 | +98.7% | 0.01% | 0.0% |
| Q3 2014 | $518,000 | -5.5% | 45,680 | +0.7% | 0.01% | 0.0% |
| Q2 2014 | $548,000 | +1.9% | 45,372 | -1.8% | 0.01% | +25.0% |
| Q1 2014 | $538,000 | -36.4% | 46,213 | -3.4% | 0.00% | -42.9% |
| Q4 2013 | $846,000 | +19.5% | 47,840 | -2.7% | 0.01% | +40.0% |
| Q3 2013 | $708,000 | -1.5% | 49,168 | +3.0% | 0.01% | -16.7% |
| Q2 2013 | $719,000 | – | 47,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
| Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
| Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
| Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
| Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
| Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
| Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |